Jim Simons's position in Neogenomics is currently worth $1.52 Million. That's 0.00% of their equity portfolio (2047th largest holding). The first Neogenomics trade was made in Q4 2013. Since then Jim Simons bought shares thirteen more times and sold shares on twelve occasions. The stake costed the investor $1.48 Million, netting the investor a gain of 2.2% so far.